What are the major opportunities in the Endometriosis market? What are the strategies for the Endometriosis market?

For detailed insights on the major opportunities and strategies in the Endometriosis market, Read More

How does the Endometriosis market relate to the overall economy and other similar markets?

For detailed insights on Endometriosis's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Endometriosis market growth? SWOT analysis of the Endometriosis market.

For detailed insights on the key dynamics influencing the Endometriosis market growth and SWOT analysis of the Endometriosis industry, Read More

Endometriosis Market Global Report 2026 Market Report Infographic Image

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Endometriosis Market Report 2026

Name: Endometriosis Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Type (Superficial Peritoneal Lesion, Endometrioma, Deeply Infiltrating Endometriosis, Other Types), By Treatment Type (Hormonal Therapy, Pain Management), By Drug (Oral Contraceptives, Progestins, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Gonadotropin Releasing Hormone (GnRH) Analogues, Levonorgestrel-Releasing Intrauterine Devices (LNR-IUDs), Other Drugs), By End-User (Hospitals, Homecare, Specialty Centers, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Endometriosis Market Overview

• Endometriosis market size has reached to $1.54 billion in 2025

• Expected to grow to $2.44 billion in 2030 at a compound annual growth rate (CAGR) of 9.8%

• Growth Driver: Elevated Ovarian Cancer Incidence Fuels Growth In The Endometriosis Market

• Market Trend: Innovative Blood-Based Test Enables Early Detection Of A Chronic Gynecological Conditioncare

• North America was the largest region in 2025.

What Is Covered Under Endometriosis Market?

Endometriosis is a chronic medical condition that occurs when tissue similar to the lining of the uterus (endometrium) grows outside the uterus. The condition can cause severe pain in the pelvis and make it harder to get pregnant. It can significantly impact a person's quality of life and fertility.

The main types of endometriosis are superficial peritoneal lesions, endometrioma, deeply infiltrating endometriosis and others. A superficial peritoneal lesion refers to a specific type of abnormal tissue growth that occurs in cases of endometriosis. It includes various treatments, such as hormonal therapy and pain management. These diseases can be treated by various drugs, such as oral contraceptives, progestins, nonsteroidal anti-inflammatory drugs (NSAIDs), GnRH analogs, levonorgestrel-releasing intrauterine devices (LNR-IUDs) and others used by different end-users such as hospitals, homecare, specialty centers and others.

Endometriosis Market Global Report 2026 Market Report bar graph

What Is The Endometriosis Market Size and Share 2026?

The endometriosis market size has grown strongly in recent years. It will grow from $1.54 billion in 2025 to $1.68 billion in 2026 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to underdiagnosis of endometriosis, growth in gynecological consultations, rising infertility cases, hormonal therapy adoption, pain management demand.

What Is The Endometriosis Market Growth Forecast?

The endometriosis market size is expected to see strong growth in the next few years. It will grow to $2.44 billion in 2030 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to early screening initiatives, improved diagnostic accuracy, personalized treatment approaches, women’s health advocacy, expansion of specialty care. Major trends in the forecast period include rising awareness of chronic pelvic pain, increased diagnosis of fertility-related disorders, growing use of hormonal therapies, expansion of specialty gynecology centers, focus on long-term disease management.

Book your 30 minutes free consultation with our research experts

Global Endometriosis Market Segmentation

1) By Type: Superficial Peritoneal Lesion, Endometrioma, Deeply Infiltrating Endometriosis, Other Types

2) By Treatment Type: Hormonal Therapy, Pain Management

3) By Drug: Oral Contraceptives, Progestins, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Gonadotropin Releasing Hormone (GnRH) Analogues, Levonorgestrel-Releasing Intrauterine Devices (LNR-IUDs), Other Drugs

4) By End-User: Hospitals, Homecare, Specialty Centers, Other End-Users

Subsegments:

1) By Superficial Peritoneal Lesion: Minimal Lesions, Mild Lesions, Peritoneal Surface Lesions

2) By Endometrioma: Ovarian Endometrioma, Chocolate Cyst, Bilateral Endometrioma

3) By Deeply Infiltrating Endometriosis: Rectovaginal Deep Lesions, Bladder Deep Lesions, Ureteral Deep Lesions

4) By Other Types: Adenomyosis-Associated Endometriosis, Extraperitoneal Endometriosis, Rare Anatomical Site Endometriosis

What Is The Driver Of The Endometriosis Market?

The increasing incidence of ovarian cancer is expected to propel the growth of the endometriosis market going forward. Ovarian cancer is a type of cancer that begins in the ovaries, the female reproductive organs responsible for producing eggs and the hormones estrogen and progesterone. Endometriosis is associated with an increased risk of developing epithelial ovarian cancer, mainly the endometrioid and precise cell cancer subtypes, characterized by high estrogen concentrations, which can increase the risk of developing ovarian cancer. For instance, in January 2023, according to the American Cancer Society, a US-based professional organization, it is projected that approximately 19,710 new cases of ovarian cancer will be diagnosed among women in the US in 2023. Furthermore, in 2022, according to the Ovarian Cancer Research Alliance, a US-based not-for-profit organization, ovarian cancer caused 12,810 deaths in 2022 and increased to 13,270 fatalities in 2023. Therefore, the increasing incidence of ovarian cancer is driving the growth of the endometriosis industry.

Key Players In The Global Endometriosis Market

Major companies operating in the endometriosis market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck and Co. Inc., Abbvie Inc., Bayer AG, GlaxoSmithKline plc, Abbott Laboratories, Eli Lilly and Company, Mylan N.V., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Limited, Cadila Pharmaceuticals Ltd., Gedeon Richter plc, Torrent Pharmaceuticals Ltd., Ferring Pharmaceuticals, Kissei Pharmaceutical Co. Ltd., Sanofi India Ltd., Repros Therapeutics Inc., Myovant Sciences Ltd., Takeda Pharmaceutical Company Limited, ObsEva SA, Gesynta Pharma AB, Zydus Healthcare Limited

Global Endometriosis Market Trends and Insights

Major companies in the endometriosis market are developing innovative solutions, including non-invasive diagnostic assays, to improve early detection and patient management. Non-invasive diagnostic assays are tests that detect or monitor a disease without requiring surgery or inserting instruments into the body, often using blood, urine, saliva, or imaging. For instance, in July 2025, Kephera Diagnostics LLC, a US-based diagnostic laboratory, launched EndomTest, an innovative blood-based diagnostic test for endometriosis. EndomTest is a laboratory-developed test that analyzes a patient’s serum sample for the biomarkers Brain-Derived Neurotrophic Factor (BDNF) and Cancer Antigen 125 (CA125), then combines those biomarker results with selected clinical variables using a proprietary diagnostic algorithm to generate a positive or negative “rule-in” indication for endometriosis. Its unique features include a non-surgical sampling method (just a blood draw), high specificity (reported at nearly 100%) for identifying the disease, and clinical applications that span women presenting with pelvic pain, heavy menstrual bleeding, infertility, or pain with sexual intercourse.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Endometriosis Market?

In January 2024, Hera Biotech Inc., a US-based women’s-health diagnostics company acquired endometriosis diagnostic assets and associated intellectual property of Scailyte,for an undisclosed amount. With this acquisition Hera Biotech aims to accelerate the development of its next-generation endometriosis diagnostic by integrating Scailyte’s single-cell data analytics and biomarker-discovery platform. Scailyte AG is a Switzerland-based biotechnology company specializing in AI-driven single-cell analysis for precision diagnostics.

Regional Outlook

North America was the largest region in the endometriosis market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Endometriosis Market?

The endometriosis market consists of revenues earned by entities by providing services such as laparoscopy, nutritional counseling, physical therapy, diagnostic laparoscopy, fertility treatment, surgical interventions and complementary therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. The endometriosis market also includes sales of birth control pills, patches and vaginal rings. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Endometriosis Market Report 2026?

The endometriosis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the endometriosis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Endometriosis Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$1.68 billion
Revenue Forecast In 2035	$2.44 billion
Growth Rate	CAGR of 9.0% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Type, Treatment Type, Drug, End-User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Pfizer Inc., F. Hoffmann-La Roche AG, Merck and Co. Inc., Abbvie Inc., Bayer AG, GlaxoSmithKline plc, Abbott Laboratories, Eli Lilly and Company, Mylan N.V., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Limited, Cadila Pharmaceuticals Ltd., Gedeon Richter plc, Torrent Pharmaceuticals Ltd., Ferring Pharmaceuticals, Kissei Pharmaceutical Co. Ltd., Sanofi India Ltd., Repros Therapeutics Inc., Myovant Sciences Ltd., Takeda Pharmaceutical Company Limited, ObsEva SA, Gesynta Pharma AB, Zydus Healthcare Limited
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Endometriosis Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Endometriosis Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Endometriosis Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Endometriosis Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Sustainability, Climate Tech & Circular Economy

4.1.5 Industry 4.0 & Intelligent Manufacturing

4.2. Major Trends

4.2.1 Rising Awareness Of Chronic Pelvic Pain

4.2.2 Increased Diagnosis Of Fertility-Related Disorders

4.2.3 Growing Use Of Hormonal Therapies

4.2.4 Expansion Of Specialty Gynecology Centers

4.2.5 Focus On Long-Term Disease Management

5. Endometriosis Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Specialty Centers

5.3 Gynecology Clinics

5.4 Homecare Providers

5.5 Fertility Centers

6. Endometriosis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Endometriosis Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Endometriosis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Endometriosis Market Size, Comparisons And Growth Rate Analysis

7.3. Global Endometriosis Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Endometriosis Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Endometriosis Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Endometriosis Market Segmentation

9.1. Global Endometriosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Superficial Peritoneal Lesion, Endometrioma, Deeply Infiltrating Endometriosis, Other Types

9.2. Global Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hormonal Therapy, Pain Management

9.3. Global Endometriosis Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral Contraceptives, Progestins, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Gonadotropin Releasing Hormone (GnRH) Analogues, Levonorgestrel-Releasing Intrauterine Devices (LNR-IUDs), Other Drugs

9.4. Global Endometriosis Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Homecare, Specialty Centers, Other End-Users

9.5. Global Endometriosis Market, Sub-Segmentation Of Superficial Peritoneal Lesion, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Minimal Lesions, Mild Lesions, Peritoneal Surface Lesions

9.6. Global Endometriosis Market, Sub-Segmentation Of Endometrioma, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Ovarian Endometrioma, Chocolate Cyst, Bilateral Endometrioma

9.7. Global Endometriosis Market, Sub-Segmentation Of Deeply Infiltrating Endometriosis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Rectovaginal Deep Lesions, Bladder Deep Lesions, Ureteral Deep Lesions

9.8. Global Endometriosis Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Adenomyosis-Associated Endometriosis, Extraperitoneal Endometriosis, Rare Anatomical Site Endometriosis

10. Endometriosis Market Regional And Country Analysis

10.1. Global Endometriosis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Endometriosis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Endometriosis Market

11.1. Asia-Pacific Endometriosis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Endometriosis Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Endometriosis Market

12.1. China Endometriosis Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Endometriosis Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Endometriosis Market

13.1. India Endometriosis Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Endometriosis Market

14.1. Japan Endometriosis Market Overview

14.2. Japan Endometriosis Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Endometriosis Market

15.1. Australia Endometriosis Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Endometriosis Market

16.1. Indonesia Endometriosis Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Endometriosis Market

17.1. South Korea Endometriosis Market Overview

17.2. South Korea Endometriosis Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Endometriosis Market

18.1. Taiwan Endometriosis Market Overview

18.2. Taiwan Endometriosis Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Endometriosis Market

19.1. South East Asia Endometriosis Market Overview

19.2. South East Asia Endometriosis Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Endometriosis Market

20.1. Western Europe Endometriosis Market Overview

20.2. Western Europe Endometriosis Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Endometriosis Market

21.1. UK Endometriosis Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Endometriosis Market

22.1. Germany Endometriosis Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Endometriosis Market

23.1. France Endometriosis Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Endometriosis Market

24.1. Italy Endometriosis Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Endometriosis Market

25.1. Spain Endometriosis Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Endometriosis Market

26.1. Eastern Europe Endometriosis Market Overview

26.2. Eastern Europe Endometriosis Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Endometriosis Market

27.1. Russia Endometriosis Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Endometriosis Market

28.1. North America Endometriosis Market Overview

28.2. North America Endometriosis Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Endometriosis Market

29.1. USA Endometriosis Market Overview

29.2. USA Endometriosis Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Endometriosis Market

30.1. Canada Endometriosis Market Overview

30.2. Canada Endometriosis Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Endometriosis Market

31.1. South America Endometriosis Market Overview

31.2. South America Endometriosis Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Endometriosis Market

32.1. Brazil Endometriosis Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Endometriosis Market

33.1. Middle East Endometriosis Market Overview

33.2. Middle East Endometriosis Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Endometriosis Market

34.1. Africa Endometriosis Market Overview

34.2. Africa Endometriosis Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Endometriosis Market Regulatory and Investment Landscape

36. Endometriosis Market Competitive Landscape And Company Profiles

36.1. Endometriosis Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Endometriosis Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Endometriosis Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Merck and Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Abbvie Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

37. Endometriosis Market Other Major And Innovative Companies

GlaxoSmithKline plc, Abbott Laboratories, Eli Lilly and Company, Mylan N.V., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Limited, Cadila Pharmaceuticals Ltd., Gedeon Richter plc, Torrent Pharmaceuticals Ltd., Ferring Pharmaceuticals, Kissei Pharmaceutical Co. Ltd., Sanofi India Ltd., Repros Therapeutics Inc., Myovant Sciences Ltd., Takeda Pharmaceutical Company Limited

38. Global Endometriosis Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Endometriosis Market

40. Endometriosis Market High Potential Countries, Segments and Strategies

40.1 Endometriosis Market In 2030 - Countries Offering Most New Opportunities

40.2 Endometriosis Market In 2030 - Segments Offering Most New Opportunities

40.3 Endometriosis Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Endometriosis Market, Overview Of Key Products - Product Examples

Table 2: Global Endometriosis Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Endometriosis Market, Supply Chain Analysis

Table 4: Global Endometriosis Market, Major Raw Material Providers

Table 5: Global Endometriosis Market, Major Resource Providers

Table 6: Global Endometriosis Market, Major Manufacturers (Suppliers)

Table 7: Global Endometriosis Market, Major Distributors And Channel Partners

Table 8: Global Endometriosis Market, Key Technologies & Future Trends

Table 9: Global Endometriosis Market, Major Trends

Table 10: Global Endometriosis Market, Major End Users

Table 11: Global Endometriosis Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Endometriosis Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Endometriosis Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Endometriosis Market - TAM, US$ Billion, 2025

Table 15: Global Endometriosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Endometriosis Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Endometriosis Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Endometriosis Market, Sub-Segmentation Of Superficial Peritoneal Lesion, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Endometriosis Market, Sub-Segmentation Of Endometrioma, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Endometriosis Market, Sub-Segmentation Of Deeply Infiltrating Endometriosis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Endometriosis Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Endometriosis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Endometriosis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Endometriosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Endometriosis Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Endometriosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Endometriosis Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Endometriosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Endometriosis Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Endometriosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Endometriosis Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Endometriosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Endometriosis Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Endometriosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Endometriosis Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Endometriosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Endometriosis Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Endometriosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Endometriosis Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Endometriosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Endometriosis Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Endometriosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Endometriosis Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Endometriosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Endometriosis Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Endometriosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Endometriosis Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Endometriosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Endometriosis Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Endometriosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Endometriosis Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Endometriosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Endometriosis Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Endometriosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Endometriosis Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Endometriosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Endometriosis Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Endometriosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Endometriosis Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Endometriosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Endometriosis Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Endometriosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Endometriosis Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Endometriosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Endometriosis Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Endometriosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Endometriosis Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Endometriosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Endometriosis Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Endometriosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Endometriosis Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Global Endometriosis Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 98: Global Endometriosis Market - Company Scoring Matrix

Table 99: Pfizer Inc. Financial Performance

Table 100: F. Hoffmann-La Roche AG Financial Performance

Table 101: Merck and Co. Inc. Financial Performance

Table 102: Abbvie Inc. Financial Performance

Table 103: Bayer AG Financial Performance

Table 104: Global Endometriosis Market, Competitive Benchmarking (In USD Billions)

Table 105: Global Endometriosis Market, Competitive Dashboard

Table 106: Global Endometriosis Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 107: Global, Endometriosis Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Table 108: Global, Endometriosis Market Size Gain ($ Billion), Segmentation By Treatment Type, 2025 – 2030

Table 109: Global, Endometriosis Market Size Gain ($ Billion), Segmentation By Drug, 2025 – 2030

List Of Figures

Figure 1: Global Endometriosis Market, Overview Of Key Products - Product Examples

Figure 2: Global Endometriosis Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Endometriosis Market, Supply Chain Analysis

Figure 4: Global Endometriosis Market, Major Raw Material Providers

Figure 5: Global Endometriosis Market, Major Resource Providers

Figure 6: Global Endometriosis Market, Major Manufacturers (Suppliers)

Figure 7: Global Endometriosis Market, Major Distributors And Channel Partners

Figure 8: Global Endometriosis Market, Key Technologies & Future Trends

Figure 9: Global Endometriosis Market, Major Trends

Figure 10: Global Endometriosis Market, Major End Users

Figure 11: Global Endometriosis Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Endometriosis Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Endometriosis Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Endometriosis Market - TAM, US$ Billion, 2025

Figure 15: Global Endometriosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Endometriosis Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Endometriosis Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Endometriosis Market, Sub-Segmentation Of Superficial Peritoneal Lesion, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Endometriosis Market, Sub-Segmentation Of Endometrioma, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Endometriosis Market, Sub-Segmentation Of Deeply Infiltrating Endometriosis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Endometriosis Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Endometriosis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Endometriosis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Endometriosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Endometriosis Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Endometriosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Endometriosis Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Endometriosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Endometriosis Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Endometriosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Endometriosis Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Endometriosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Endometriosis Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Endometriosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Endometriosis Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Endometriosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Endometriosis Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Endometriosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Endometriosis Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Endometriosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Endometriosis Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Endometriosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Endometriosis Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Endometriosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Endometriosis Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Endometriosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Endometriosis Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Endometriosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Endometriosis Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Endometriosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Endometriosis Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Endometriosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Endometriosis Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Endometriosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Endometriosis Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Endometriosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Endometriosis Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Endometriosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Endometriosis Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Endometriosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Endometriosis Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Endometriosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Endometriosis Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Endometriosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Endometriosis Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Endometriosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Endometriosis Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Endometriosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Endometriosis Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Endometriosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Endometriosis Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Global Endometriosis Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 98: Global Endometriosis Market - Company Scoring Matrix

Figure 99: Pfizer Inc. Financial Performance

Figure 100: F. Hoffmann-La Roche AG Financial Performance

Figure 101: Merck and Co. Inc. Financial Performance

Figure 102: Abbvie Inc. Financial Performance

Figure 103: Bayer AG Financial Performance

Figure 104: Global Endometriosis Market, Competitive Benchmarking (In USD Billions)

Figure 105: Global Endometriosis Market, Competitive Dashboard

Figure 106: Global Endometriosis Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 107: Global, Endometriosis Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Figure 108: Global, Endometriosis Market Size Gain ($ Billion), Segmentation By Treatment Type, 2025 – 2030

Figure 109: Global, Endometriosis Market Size Gain ($ Billion), Segmentation By Drug, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Endometrial Cancer Treatment Market Report 2026 - Global Outlook – By Type (Adenocarcinoma, Uterine Carcinosarcoma, Squamous Cell Carcinoma, Small Cell Carcinoma, Transitional Carcinoma, Serous Carcinoma, Other Types), B...

Endometrial Ablation Devices Market Report 2026 - Global Outlook – By Device Type (Hysteroscopy Devices, Thermal Balloon Ablators, Radiofrequency Endometrial Ablation Devices, Hydrothermal Ablators, Electrical Ablators, ...

Uterine Fibroids Treatment Market Report 2026 - Global Outlook – By Type (Subserosal Fibroids, Intramural Fibroids, Submucosal Fibroids, Pedunculated Fibroids), By Treatment Type (Hormone Therapy, Androgens, Gonadotropin...

Cyclic Heavy Menstrual Bleeding Market Report 2026 - Global Outlook – By Treatment Type (Pharmaceuticals, Surgical Or Procedural, Medical Devices), By Etiology (Hormonal Disorders, Structural Abnormalities, Coagulopathie...

Gynecological Devices Market Report 2026 - Global Outlook – By Device (Surgical Devices, Hand-Held Instruments), By Application (Laparoscopy, Hysteroscopy, Dilation And Curettage, Colposcopy, Other Applications), By End ...

Gynecology Drugs Market Report 2026 - Global Outlook – By Therapeutics (Hormonal Therapy, Non-Hormonal Therapy), By Indication (Gynecology Cancers, Menopausal Disorder, Polycystic Ovary Syndrome, Contraception, Other Ind...

Frequently Asked Questions

How big is the Endometriosis Market?

The Endometriosis market was valued at $1.54 billion in 2025, increased to $1.68 billion in 2026, and is projected to reach $2.44 billion by 2030.

What is the Endometriosis market growth?

The global Endometriosis market is expected to grow at a CAGR of 9.8% from 2026 to 2035 to reach $2.44 billion by 2035.

Who are the key players in Endometriosis market?

Some Key Players in the Endometriosis market Include, Pfizer Inc., F. Hoffmann-La Roche AG, Merck and Co. Inc., Abbvie Inc., Bayer AG, GlaxoSmithKline plc, Abbott Laboratories, Eli Lilly and Company, Mylan N.V., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Limited, Cadila Pharmaceuticals Ltd., Gedeon Richter plc, Torrent Pharmaceuticals Ltd., Ferring Pharmaceuticals, Kissei Pharmaceutical Co. Ltd., Sanofi India Ltd., Repros Therapeutics Inc., Myovant Sciences Ltd., Takeda Pharmaceutical Company Limited, ObsEva SA, Gesynta Pharma AB, Zydus Healthcare Limited .

What is the anticipated growth trend for the Endometriosis market?

Major trend in this market includes: Innovative Blood-Based Test Enables Early Detection Of A Chronic Gynecological Conditioncare. For further insights on this market. request a sample here

Which region has the most growth potential in the Endometriosis market?

North America was the largest region in the endometriosis market in 2025. The regions covered in the endometriosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.